毅嘉管理顧問股份有限公司
Update:2026/01/07
Industries
Main Industry
Professional Services
Main Product/Service
Definition of prodrug: Use chemical engineering methods that connect an existing drug with a promoiety to form a prodrug.
The prodrug technology we developed can resolve developmental barriers of certain drug candidates; such as solubility, chemical stabi
The prodrug technology we developed can resolve developmental barriers of certain drug candidates; such as solubility, chemical stabi
Founded Year
2019
Unified Business No.
54996030
Status
Closed
Number of Employees
0
Total Paid-in
Capital
1,000,000 (NT$)
Location of Company
Taiwan
, Tainan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BoYen Therapeutics Inc. was established in June 2010. In its early years BoYen Therapeutics focused on new drug research and discovery, through our own proprietary prodrug technology platform, we perform chemosynthesis modification and create new patentab